Novo Nordisk Cut 7,800 Jobs — Then Upskilled 68,800 Employees With OpenAI

What happens when a 68,000-person pharmaceutical giant decides to restructure its entire workforce before investing in AI upskilling? That's exactly what Novo Nordisk did — and the sequencing was intentional. In this episode, we break down how Novo Nordisk eliminated 7,800 roles, hired 2,000 new ones designed around AI, deployed an internal AI tool called NNGPT to 17,000 employees, and then announced a company-wide OpenAI partnership to upskill all 68,800 employees. The order wasn't accidental — it was the strategy. We cover the two-phase playbook: restructure first, then upskill. Why does this matter for HR leaders? Because doing both at the same time sends contradictory signals to your workforce. Novo Nordisk separated the pain from the opportunity — and that psychological sequencing may be the most underrated part of their approach. Plus: the jaw-dropping data on clinical study reports. AI went from 50 writers and 15 weeks to 10 minutes and 3 reviewers. The system costs less per year than a single medical writer's salary.